The Next Generation of Gastrointestinal Endoscopy

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Machine Learning and Artificial Intelligence in Diagnostics".

Deadline for manuscript submissions: closed (31 July 2022) | Viewed by 3284

Special Issue Editor


E-Mail Website
Guest Editor
Division of Gastroenterology and Nephrology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Yonago, Japan
Interests: narrow-band imaging (NBI); blue laser imaging (BLI); linked color imaging (LCI); image-enhanced endoscopies (IEE); artificial intelligence (AI); computer-aided diagnosis (CAD); endoscopic submucosal dissection (ESD); endocytoscopy
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue focusses on the latest imaging modalities in the field of gastrointestinal (GI) endoscopy, as well as current innovations, mainly regarding the development of artificial intelligence (AI). Computer-aided diagnosis (CAD) is garnering increased investigation. Tracking suspicious lesions needs to be performed with the aim of screening in real time to afford automated diagnoses during on-going endoscopic procedures. Although AI solutions are at a more advanced stage of development not only for colonic diseases but also for conditions of the upper GI tract, there have been promising reports concerning the use of AI application in GI endoscopy. Meanwhile, novel imaging modalities such as TXI (texture and color enhancement imaging), RDI (red dichromatic imaging), LCI (linked color imaging), and IRI (infra-red imaging) have been developed and readily used in clinical practice for tumors and non-tumorous lesions in the whole digestive tract from oropharyngus to anorectum with advancement of the corresponding image-enhanced endoscopes equipped with an ultra-magnifying function. The development of other novel endoscopic diagnostic modalities and imaging techniques is upcoming or ongoing.

This Special Issue will be beneficial in disseminating knowledge on how endoscopic imaging is developing and enabling readers to foresee the future of diagnostic luminal endoscopy in which endoscopists should not compromise pre-existing and ever developing diagnostic performance in the GI endoscopic field.

Dr. Hajime Isomoto
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • gastrointestinal endoscopy
  • artificial intelligence
  • computer-aided diagnosis

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

12 pages, 1860 KiB  
Article
Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer in the Remnant Stomach
by Mai Murakami, Takuto Hikichi, Jun Nakamura, Minami Hashimoto, Tsunetaka Kato, Ryoichiro Kobashi, Takumi Yanagita, Rei Suzuki, Mitsuru Sugimoto, Yuki Sato, Hiroki Irie, Mika Takasumi, Tadayuki Takagi, Yuko Hashimoto, Masao Kobayakawa and Hiromasa Ohira
Diagnostics 2022, 12(10), 2480; https://doi.org/10.3390/diagnostics12102480 - 13 Oct 2022
Viewed by 1347
Abstract
Endoscopic submucosal dissection (ESD) in patients with early gastric cancers (EGCs) in the remnant stomach is technically difficult, owing to the limited space and fibrosis under the suture lines and anastomoses. Conversely, ESD for patients with EGCs in the remnant stomach is less [...] Read more.
Endoscopic submucosal dissection (ESD) in patients with early gastric cancers (EGCs) in the remnant stomach is technically difficult, owing to the limited space and fibrosis under the suture lines and anastomoses. Conversely, ESD for patients with EGCs in the remnant stomach is less invasive and provides better quality of life than completion total gastrectomy. To clarify the effectiveness and safety of ESD, we reviewed the medical records of patients with EGCs in the remnant stomach who underwent ESD between July 2006 and October 2020 at our institution. All identified patients were included in the analysis. Of 25 patients with 27 lesions, the en bloc and R0 resection rates were 88.9% and 85.2%, respectively. Neither perforation nor postoperative bleeding was observed. During a median follow-up period of 48 (range, 5–162) months, the 5-year overall survival rate was 71.0%, whereas the 5-year cause-specific survival rate was 100%. No obvious differences in the outcomes of procedures with suture line involvement and without suture line or anastomosis involvement were noted. In conclusion, ESD was effective and safe in patients with EGCs in the remnant stomach despite the suture line involvement. Full article
(This article belongs to the Special Issue The Next Generation of Gastrointestinal Endoscopy)
Show Figures

Figure 1

8 pages, 1396 KiB  
Article
Usefulness of Practitioner-Led Pancreatic Cancer Screening
by Kazuya Matsumoto, Yoshinori Kushiyama, Akio Izumi, Koji Ohnishi, Masahiko Miura, Yasufumi Ohuchi, Ikuko Hori, Tomonori Nakamura, Kotaro Hori, Kenji Koshino, Junko Kobayashi, Nagisa Yoshino, Ushio Hoshino, Takekiyo Okumura, Takashi Tanimura, Shinsuke Tanaka, Shino Tanaka, Tadashi Nabika, Tatsuaki Nozu, Yutaka Wakatsuki, Syunsuke Katayama, Shizue Yoshioka, Kenichi Ito, Akiko Uchida, Noriji Yuhara, Hisashi Noma and Hajime Isomotoadd Show full author list remove Hide full author list
Diagnostics 2022, 12(9), 2257; https://doi.org/10.3390/diagnostics12092257 - 19 Sep 2022
Cited by 1 | Viewed by 1472
Abstract
The 5-year survival rate for pancreatic cancer has improved (10%) but remains worse than that for other cancers. Early pancreatic cancer diagnosis is challenging, and delayed diagnosis can delay treatment, which impairs survival. Practitioners do not promptly refer cases to a general hospital, [...] Read more.
The 5-year survival rate for pancreatic cancer has improved (10%) but remains worse than that for other cancers. Early pancreatic cancer diagnosis is challenging, and delayed diagnosis can delay treatment, which impairs survival. Practitioners do not promptly refer cases to a general hospital, causing delayed discovery. Herein, we aimed to examine the usefulness of the Pancreatic Cancer Project in Matsue, whose objective is to detect pancreatic cancer in patients presenting at any medical institution in Matsue City. Clinical data were extracted from medical records, and abdominal ultrasonography and tumor marker blood level assessments were performed (n = 234; median age, 71 [range, 41–94] years; 51% male). Cases with abnormal abdominal ultrasonography or blood test findings were referred for specialist imaging and followed up. The pancreatic cancer detection rate was 6.0% (n = 14); all cases were referred to a general hospital by practitioners within 1 month. Patients had stage IA (n = 1), IIA (n = 6), IIB (n = 2), III (n = 1), and IV (n = 4) disease. Overall, pancreatic cancer could be detected at an earlier stage (I–II), but referral to a general hospital by visiting practitioners should be prompt. The Pancreatic Cancer Project in Matsue may help improve the detection and prognosis of pancreatic cancer. Full article
(This article belongs to the Special Issue The Next Generation of Gastrointestinal Endoscopy)
Show Figures

Figure 1

Back to TopTop